Here are three things to know:
1. Sonavex is a point-of-care imaging technology company. EchoMark is the first product in Sonavex’s new technology portfolio to receive FDA clearance.
2. EchoMark and EchoMark LP are echogenic, resorbable polymeric implants used for marking soft tissue sites in surgical patients. EchoMark’s ultrasound reflective properties and 3D shape are engineered to allow surgeons to mark surgical sites for clear ultrasound visualization during follow-up evaluations.
3. Sonavex recently closed a series A financing round and was awarded a Small Business Innovation Research Phase II supplement grant from the National Science Foundation.
More articles on imaging:
OrthAlign hits clinical milestone: 2k HipAlign cases performed
Dr. Bernard Stulberg performs 1st US knee replacement with ExactechGPS: 3 things to know
